Detection of KRAS and BRAF point mutations from circulating DNA analysis and concordance with tumor-tissue analysis in metastatic colorectal cancer, 2013. ,
Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.26, issue.10, pp.1626-1660, 2008. ,
DOI : 10.1200/JCO.2007.14.7116
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website, British Journal of Cancer, vol.300, issue.912, pp.355-363, 2004. ,
DOI : 10.1093/nar/gkh073
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments, Clinical Chemistry, vol.55, issue.4, pp.611-633, 2009. ,
DOI : 10.1373/clinchem.2008.112797
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing, Clinical Chemistry, vol.59, issue.1, pp.211-235, 2013. ,
DOI : 10.1373/clinchem.2012.196014
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer, New England Journal of Medicine, vol.368, issue.13, pp.1199-209, 1056. ,
DOI : 10.1056/NEJMoa1213261
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutationspecific drug responses, Proc Natl Acad Sci, issue.10552, pp.20864-20873, 2008. ,
Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.26, issue.35, pp.5705-5717, 2008. ,
DOI : 10.1200/JCO.2008.18.0786
Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proceedings of the National Academy of Sciences, vol.102, issue.45, pp.16368-73, 2005. ,
DOI : 10.1073/pnas.0507904102
Circulating mutant DNA to assess tumor dynamics, Nature Medicine, vol.3, issue.9, pp.985-90, 2008. ,
DOI : 10.1038/nm.1789
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820391
Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients, Gastroenterology, vol.135, issue.2, pp.489-98, 2008. ,
DOI : 10.1053/j.gastro.2008.05.039
Mutations in Colorectal Cancer, New England Journal of Medicine, vol.369, issue.11, pp.1023-1057, 1056. ,
DOI : 10.1056/NEJMoa1305275
Circulating cell free DNA: Preanalytical considerations, Clinica Chimica Acta, vol.424, 2013. ,
DOI : 10.1016/j.cca.2013.05.022
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer, The Journal of Urology, vol.181, issue.1, pp.363-71, 2009. ,
DOI : 10.1016/j.juro.2008.08.118
Methods for isolation of cell-free plasma DNA strongly affect DNA yield, Clinica Chimica Acta, vol.412, issue.23-24, pp.23-242085, 2011. ,
DOI : 10.1016/j.cca.2011.07.011
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA, Science Translational Medicine, vol.4, issue.136, pp.136-68, 2012. ,
DOI : 10.1126/scitranslmed.3003726
Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells, Cancer Research, vol.70, issue.2, pp.560-567, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-3513
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA, Biomarkers, vol.25, issue.6, pp.498-506, 2012. ,
DOI : 10.1016/S0305-7372(02)00077-4
Differential strand separation at critical temperature: A minimally disruptive enrichment method for low-abundance unknown DNA mutations, Nucleic Acids Research, vol.41, issue.3, pp.50-60, 1250. ,
DOI : 10.1093/nar/gks1250
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing, Cancer Research, vol.73, issue.10, pp.2965-75, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-4140
Cancer drug resitance: an evolving paradigm, Nat Rev Cancer, pp.10-1038, 2013. ,
DOI : 10.1038/nrc3599
Cell-free DNA in the blood as a solid tumor biomarker???A critical appraisal of the literature, Clinica Chimica Acta, vol.411, issue.21-22, pp.21-221611, 2010. ,
DOI : 10.1016/j.cca.2010.07.032
Free DNA in the serum of cancer patients and the effect of therapy, Cancer Res, issue.373, pp.646-50, 1977. ,
Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-383, 2008. ,
DOI : 10.1200/JCO.2007.12.5906
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer, Cancer Research, vol.66, issue.8, pp.3992-3997, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-0191
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer, Nature, vol.102, issue.4867404, pp.532-538, 2012. ,
DOI : 10.1038/nature11156
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load, Translational Oncology, vol.6, issue.3, pp.319-347, 2013. ,
DOI : 10.1593/tlo.12445
URL : https://hal.archives-ouvertes.fr/hal-00872683
High Fragmentation Characterizes Tumour-Derived Circulating DNA, PLoS ONE, vol.27, issue.9, 2011. ,
DOI : 10.1371/journal.pone.0023418.s003
URL : http://doi.org/10.1371/journal.pone.0023418
The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients, Expert Opinion on Biological Therapy, vol.25, issue.3, pp.209-224, 2012. ,
DOI : 10.1111/j.1365-2567.2005.02130.x
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA, Nature, vol.405, issue.7447, pp.108-120, 1038. ,
DOI : 10.1038/nature12065
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing, Cancer Research, vol.72, issue.14, pp.3492-3500, 2012. ,
DOI : 10.1158/0008-5472.CAN-11-4037
Radiation-generated Short DNA Fragments May Perturb Non-homologous End-joining and Induce Genomic Instability, Journal of Radiation Research, vol.52, issue.3, pp.309-328, 2011. ,
DOI : 10.1269/jrr.10147
Review of the current status of KRAS mutation testing in France in 2011: The Flash-KRAS study, Journal of Clinical Oncology, vol.14129, issue.30, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00747407
Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers, PLoS One, issue.711, 2012. ,
Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content, Expert Opinion on Biological Therapy, vol.28, issue.4, pp.141-53, 2012. ,
DOI : 10.1111/j.1464-410X.2006.06352.x
Multiparametric Analysis of Cell-Free DNA in Melanoma Patients, PLoS ONE, vol.5, issue.11, 2012. ,
DOI : 10.1371/journal.pone.0049843.s002
Integrity of Cell-Free Plasma DNA in Patients with Lung Cancer and Nonmalignant Lung Disease, Annals of the New York Academy of Sciences, vol.77, issue.1, 2008. ,
DOI : 10.1196/annals.1448.034
Chromatin organization marks exon-intron structure, Nature Structural & Molecular Biology, vol.448, issue.9, 2009. ,
DOI : 10.1038/nsmb.1659
Cell-free nucleic acids as biomarkers in cancer patients, Nature Reviews Cancer, vol.61, issue.83, pp.426-463, 2011. ,
DOI : 10.1038/nrc3066
Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan, Clinical Cancer Research, vol.18, issue.4, pp.1177-85, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-0564
Isolation and characterization of DNA from the plasma of cancer patients, European Journal of Cancer and Clinical Oncology, vol.23, issue.6, pp.707-719, 1987. ,
DOI : 10.1016/0277-5379(87)90266-5
About the possible origin and mechanism of circulating DNA, Clinica Chimica Acta, vol.313, issue.1-2, pp.139-181, 2001. ,
DOI : 10.1016/S0009-8981(01)00665-9
Detecting biomarkers with microdroplet technology, Trends in Molecular Medicine, vol.18, issue.7, pp.405-421, 2012. ,
DOI : 10.1016/j.molmed.2012.05.001
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Research, vol.38, issue.18, pp.6159-6175, 2010. ,
DOI : 10.1093/nar/gkq421
Mutation Status, Journal of Clinical Oncology, vol.29, issue.15, pp.2011-2020, 2011. ,
DOI : 10.1200/JCO.2010.33.5091
Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?, Clinical Biochemistry, vol.43, issue.1-2, pp.26-36, 2010. ,
DOI : 10.1016/j.clinbiochem.2009.08.027
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients, British Journal of Cancer, vol.26, issue.10, pp.1519-1542, 2010. ,
DOI : 10.1016/j.humpath.2007.04.008
Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation, Nucleic Acids Research, vol.40, issue.11, 2012. ,
DOI : 10.1093/nar/gks203